Page last updated: 2024-08-23

epirubicin and Lymphoma, T Cell, Peripheral

epirubicin has been researched along with Lymphoma, T Cell, Peripheral in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	2 (33.33)	29.6817
2010's	1 (16.67)	24.3611
2020's	2 (33.33)	2.80

Authors

Authors	Studies
Bai, O; Feng, X; Guo, Q; Guo, W; Li, J; Qu, L; Wang, Y; Yan, X; Young, KH; Zhao, Y	1
Wang, W; Wei, C; Zhang, W; Zhang, Y; Zhao, D; Zhou, D	1
Advani, RH; Ansell, SM; Beaven, AW; Carson, KR; Evens, AM; Foss, F; Horwitz, S; Lechowicz, MJ; Loberiza, F; Pinter-Brown, LC; Pro, B; Savage, KJ; Shustov, AR; Smith, SM; Vose, JM	1
Culligan, DJ; Johnston, PW; Milner, BJ; Mittal, S	1
Bishton, MJ; Haynes, AP	1
Barboteu, M; de Kerviler, E; Frija, J; Le Gall, JR; Monsuez, JJ; Pautier, P; Simon, D	1

Trials

2 trial(s) available for epirubicin and Lymphoma, T Cell, Peripheral

Article	Year
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial. British journal of haematology, 2016, Volume: 172, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine	2016
Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma. British journal of haematology, 2007, Volume: 136, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Celiac Disease; Combined Modality Therapy; Cytarabine; Enteral Nutrition; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome	2007

Article

Year

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.

British journal of haematology, 2016, Volume: 172, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine

2016

Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.

British journal of haematology, 2007, Volume: 136, Issue:1

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Celiac Disease; Combined Modality Therapy; Cytarabine; Enteral Nutrition; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

2007

Other Studies

4 other study(ies) available for epirubicin and Lymphoma, T Cell, Peripheral

Article	Year
The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone in Untreated PTCL: A Real-World, Retrospective Study. Advances in therapy, 2022, Volume: 39, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cyclophosphamide; Epirubicin; Humans; Lymphoma, T-Cell, Peripheral; Prednisone; Retrospective Studies	2022
Long-time follow-up of patients with untreated peripheral T cell lymphoma following chidamide combined with cyclophosphamide, epirubicin, vindesine, prednisone, and etoposide therapy: a single-center propensity score-matching study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023, Volume: 25, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, T-Cell, Peripheral; Prednisone; Propensity Score; Retrospective Studies; Vincristine; Vindesine	2023
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab. European journal of haematology, 2006, Volume: 76, Issue:6 Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Crohn Disease; Cytarabine; Epirubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Liver; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Male; Methylprednisolone; Pentostatin; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Spleen; Transplantation, Homologous; Vidarabine	2006
Non-Hodgkin's lymphoma related eosinophilic endomyocardial disease. European heart journal, 1994, Volume: 15, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Contrast Media; Doxorubicin; Echocardiography; Echocardiography, Doppler, Pulsed; Endocardium; Epirubicin; Heterocyclic Compounds; Humans; Hypereosinophilic Syndrome; Lymphoma, T-Cell, Peripheral; Magnetic Resonance Imaging; Male; Myocardium; Organometallic Compounds	1994